See the "Bull Market" in 10 years! A shares 144 companies in a single day up and down, medicine is expected to create another miracle

Guide: strong capital inflow, layout of the field of medicine good opportunities!the day before yesterday, you may be wondering if the market's sharp rise is realBanking, non-bank finance and real estate leading up may not be your area of concern, but with yesterday's large inflows of funds, the turnover of the two cities continued to hit a new high this year, only suddenly woke up to this rally or not a separate section of the matter, is now the best time to lay out the pharmaceutical industry01, under the economic recovery, the same potential of pharmaceutical stocks under the market is unlimited
although the epidemic made the first half of the listed companies earnings recovery has been hit, but also strengthened the domestic currency against the expansion of the logicAlthough the pharmaceutical industry in this environment against the trend of growth to become the capital market preferred industry, but with the steady progress of domestic resumption of work, the industry-wide earnings of listed companies are expected to return to the weak recovery track, which also means that China's potential growth rate is also expected to end the long-term downward trend, no doubt the pharmaceutical industry also includes itReflected in the stock market, which means that the past decade has not had the "medical bulls" is expected to follow this year's market openingJuly 7, the deadline, the A-share market ushered in 145 stocks rose, the pharmaceutical manufacturing industry rose less than the broader market, the rise of the middle (1.3%), Changchun High-tech, Kehua Biology and other 7 stocks rose and stopped, the capital inflow is huge, only Changchun High-tech on the day of the net inflow of funds reached 371 million yuan, ranking fifth in the A-share inflow fundsinflow of funds from the pharmaceutical manufacturing industry
A-share market capital inflows into the top fiveand Changchun High-tech in the pharmaceutical industry so bright, the reason is that the half-year forecast released at noon on July 7, 2020 is expected to be net profit of 1.235 billion yuan - 1,381 million yuan, up 70%-90% year-on-yearThe reason for the change was the merger of the income growth of the controlling backbone pharmaceutical enterprise stake and the financial statements of Kinsey Pharmaceuticals02, ferocious market, do not lose their sanity
eye red brokerage sand brokerage and other industries stocks continued to rise and fall, but also to know the logic behind it? Market funds expect their performance to thicken in a bull market environment, coupled with the upcoming interim results disclosure period, are the brokerage stocks to support the riseHowever, with the interpretation of the logic of the bull market, the performance of brokerage stocks in it may tend to averageAlthough from the capital side and the market side, the Shanghai and Shenzhen stock markets into a bull market seems to be an indisputable factHowever, the author believes that in the face of the current fierce market, investors should still maintain a trace of rationalitywith the first half of the year, the stock market in the second half of this year is also destined to be a bull market for valuation repair and valuation growth, rather than historical economic outbursts and changes such as the industrial revolutionThe performance of the aviation, tourism, catering and listed companies, which are dominated by international markets, will not only not grow, but may even continue to lose big losses, and their share prices will not rise, they may continue to fall in the coming round of structural bull marketscompared to this, pharmaceutical stocks as the first half of the beneficiaries, you say it is a "national difficult ies" also, but at least the company's performance is realistic, the second half of the year may lead the A-share industryFor small and medium-sized investors, the first thing to do is to carefully study the fundamentals of listed companies, in line with the law of the market, to obtain the greatest returnthe author has three suggestions, only for everyone as far as possible to grasp the lifeblood of the industry1Bull market early: the industry-wide layoutthe bull market is the beginning of the end, who will be the focus, who can not foresee, but we can choose the flow of funds to judge the market, large market funds go where, we can keep up, do not want to eat meat, drink a few days of soup is completely unproblematic, to yesterday's market, for example, in the pharmaceutical sector market is not good, there are still a large amount of funds inflow, combined with the day's announcement content and timethat is, no matter which enterprise is laid out, in the early stage of the bull market will not lose, but with the larger the movement of funds, the pharmaceutical industry is more beneficial2Bull market in the middle: precise layout, preferably low or not high valuation of enterprises, to the bull market in the middle of the market, the more with the passage of time, the more cautious funds, crazy after often followed by parity, this time blind investment, will become the eyes of othersPreferably, a pharmaceutical stock with a low valuation and no problems operating will largely avoid taking the wrong step3Bull market late: the rapids retreat, after the tide must be a mess afterbig waves, often left full of fish and shrimp, the real brave will certainly choose the right time to choose to exit, birds do not hide or inappropriate, but history can be like Zhang Liang good start and end of the celebrity few, the stock market can really do after the bull market can stand high on the more a few, you know, you will always earn your team-mates 03, summary stand in a longer-term perspective, although the macro environment is complex and changeable, but the two major trends have not changed, is that most of the physical sectors of the industry are experiencing "recovery", can be in others to recover, the choice of progress of the only pharmaceutical industry Second, science and technology is the truth, selling rice, selling potatoes can only feed, want to the country rich and strong, science and technology development is the best shortcut, reflected in the pharmaceutical industry is equally applicable, can lead the overall progress and development of the pharmaceutical industry is only the only way to innovate Innovative drugs, innovative medical devices, innovative surgical methods, innovative formulation research and development, and so on are all areas with unlimited future potential look forward to the second half of the year, the author believes that in the global economic recovery superimposed low interest rates in the macro environment, in terms of capital markets, the field of medicine is my insistence, but also a look forward to me After half a year of industrial upgrading, industry concentration, economic recovery, liquidity easing may become the pharmaceutical industry development keywords, hope in this stick, can really see the pharmaceutical industry leading the city that day recommended Reading: 1 America's largest health care products company declared bankruptcy, ha drug shares 2 billion investment or water drift! 2 the next day the big fall, two big news shock pharmaceutical stock market, the current capital market investment proposal 3.4 pharmaceutical giants have hit the wall, $40 billion market into the "sky pavilion"? 4.22 years of struggle, the final listing, Gan Li Pharmaceuticals vowed to "insulin" domestic substitution to the end of the 5 "Big flip" or "one empty"? New preparation plus holding, Gilead multi-directional exploration..